On September 19th the Venture Challenge Fall 2022 will commence!

During an intense 10 weeks, the 5 selected teams will develop a solid business case to bring their scientific invention to market and benefit researchers, doctors and patients.

The teams entering this edition of the Venture Challenge are:

Beephonix - a dynamic biomimetic microphone - Martijn Agterberg, Radboud University

D4 Diagnostics - filling the diagnostic gap with DNA-based cell counting - Pieter A. van der Velden, Leiden University Medical Center

MoVax - Genetic engineering technologies for high efficiency production of protein therapeutics, applied in Mircoalgal Oral Vaccins - Christian Südfeld, Wageningen University & Research

NatInLab - development of medicines against viral respiratory tract infections by stimulating cell self-immune resistance through the regulation of proteolytic pathways - Ewelina Weglarz-Tomczak

PrecorDx - reducing heart failure hospitalizations with wearable diagnostics - Bart Steensma, University Medical Center Utrecht

The process

These teams of academic entrepreneurs in the life sciences will be guided by business experts, seasoned entrepreneurs during 3-day bootcamp sessions. At the end of the Venture Challenge program, the participants will pitch their plans to a jury of experienced entrepreneurs and investors, who will also select the winner of a cheque for 25,000 euros. On 24 November, during the Dutch Life Sciences Conference, the winner will be announced.

Check our website for news on te Venture Challenge.


impression of previous Venture Challenge edition

‹ News overview